title: Levosimendan in acute decompensation of anthracycline-induced cardiotoxicity.
authors.forename: José A P
authors.initials: JA
authors.lastname: Garcia
authors.forename: Luiz F N
authors.initials: LF
authors.lastname: Simvoulidis
authors.forename: Jorge I F
authors.initials: JI
authors.lastname: Salluh
authors.forename: Maria H A
authors.initials: MH
authors.lastname: Hansen
authors.forename: Guilherme A
authors.initials: GA
authors.lastname: Feres
authors.forename: Gustavo S
authors.initials: GS
authors.lastname: Holanda
authors.forename: Roberto C S
authors.initials: RC
authors.lastname: Souza
authors.forename: Luisa
authors.initials: L
authors.lastname: Toscano
authors.forename: Márcio
authors.initials: M
authors.lastname: Soares
mesh_terms: D000208:Acute Disease; D000328:Adult; D018943:Anthracyclines / Q000009:adverse effects* / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy / Q000601:surgery; D017024:Chemotherapy, Adjuvant; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D005500:Follow-Up Studies; D006333:Heart Failure / Q000139:chemically induced* / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D006835:Hydrazones / Q000008:administration & dosage*; D007262:Infusions, Intravenous; D011724:Pyridazines / Q000008:administration & dosage*; D000077464:Simendan; D016896:Treatment Outcome
chemical_list: D018943:Anthracyclines; D006835:Hydrazones; D011724:Pyridazines; D000077464:Simendan